Northrop Grumman's $95 Billion Backlog and the One Buffett Box It Can't Check

What Is Northrop Grumman?

Northrop Grumman Corporation is one of the largest defense contractors in the world, supplying the U.S. military and allied governments with some of the most technically complex and strategically critical platforms in existence. The company operates through four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Founded in 1939 and headquartered in Falls Church, Virginia, Northrop Grumman generated $41.95 billion in revenue in fiscal year 2025.

The company's most high-profile program is the B-21 Raider — the U.S. Air Force's next-generation stealth bomber designed to penetrate advanced air defenses and carry both conventional and nuclear payloads. The B-21 is arguably the most important new weapons platform in a generation, and Northrop is the sole builder. Beyond that, Northrop's portfolio spans ballistic missile systems, satellite systems (including the James Webb Space Telescope), electronic warfare, and the Ground Based Strategic Deterrent (GBSD) — the replacement for the aging Minuteman III intercontinental ballistic missile force.

Northrop's competitive moat is built on classified know-how, government certifications, and long-cycle programs that take years — sometimes decades — to develop and field. Once a contractor wins a major program, it's extremely difficult for competitors to displace them. This creates highly predictable, long-duration revenue streams tied to national security priorities rather than consumer sentiment or economic cycles. The record backlog of $95.7 billion as of year-end 2025 underscores just how locked-in that demand is.

How Northrop Grumman Scores on All 9 Buffettology Criteria

Northrop Grumman earns 8 out of 9 on the Buffettology scoring system. Here's how it performs on each criterion.

1. High Return on Equity — PASS (25.1%)

Buffettology requires ROE above 12%. Northrop's 25.1% ROE for fiscal year 2025 easily clears this bar. This is a particularly meaningful figure because defense contractors don't rely on extraordinary leverage to manufacture returns — Northrop's ROE reflects genuine operational efficiency driven by high-value programs with predictable cost structures and long-term government contracts.

2. High Return on Invested Capital — PASS

ROIC measures how effectively a company deploys both debt and equity capital. Northrop's ROIC is comfortably above the 9% threshold, reflecting the economics of a business that wins multi-billion-dollar programs and then collects payments — often with progress billing — over many years. The B-21 and GBSD programs in particular represent decades of funded work ahead.

3. Cash Machine — PASS ($3.3B FCF)

This criterion evaluates whether the company consistently converts revenue into free cash flow. Northrop generated $3.3 billion in free cash flow in fiscal year 2025, up 26.2% year over year. For a company with $41.95 billion in revenue, this represents a meaningful cash conversion rate that supports dividends, share buybacks, and ongoing R&D investment without requiring external financing.

4. Fair Valuation — PASS (~4.0% Earnings Yield)

The earnings yield (the inverse of the P/E ratio) must exceed 3.5% to pass this criterion. With a trailing P/E around 25x and EPS of $29.08 for fiscal year 2025, Northrop's earnings yield is approximately 3.9-4.0% — modestly above the threshold. This is the thinnest margin among the passing criteria, and it bears watching: if the stock continues its 2026 rally without proportional earnings growth, this criterion could come under pressure.

5. Share Buybacks — PASS

Northrop Grumman has a consistent history of returning capital to shareholders through buybacks and dividends. The company's share count has declined over time, reflecting a management team that prioritizes shareholder returns over empire-building. Alongside buybacks, Northrop pays a meaningful quarterly dividend, making it a reliable income stock within the defense sector.

6. Defensible Moat — FAIL

This is where Northrop falls short of a perfect 9. The criterion measures gross margin as a proxy for competitive moat and pricing power — with a threshold typically around 40%. Defense contractors, including Northrop, operate primarily on cost-plus and fixed-price contracts with the U.S. government, which structurally compress gross margins relative to consumer or software businesses. Northrop's gross margins run in the mid-to-high teens — well below the 40% threshold. This isn't a sign of a weak business; it's a reflection of how defense contracting economics work. The moat is real — but it's expressed through program lock-in and technical classification, not pricing power over commodity buyers.

7. Simple Business — PASS

This qualitative criterion asks whether the business is understandable, non-speculative, and durable. Northrop Grumman makes aircraft, missiles, satellites, and electronic warfare systems for the U.S. government and its allies. The customers are sovereign governments. The demand driver is national security. The revenue model is long-term contracts with defined milestones and progress payments. It's a complex business technically — but economically, it's highly legible.

8. Conservative Debt — PASS (D/E ~0.91x)

The threshold is 1.5x debt-to-equity. Northrop's debt-to-equity ratio of approximately 0.91x for fiscal year 2025 — with $15.2 billion in long-term debt against $16.0 billion in shareholder equity — passes this test. EBIT covers interest expense at 7.8x, indicating the debt load is well-managed. Defense contractors routinely carry more debt than consumer businesses given the capital intensity of major programs, but Northrop's balance sheet is not a concern at current levels.

9. Consistent Growth — PASS (Positive Five-Year Net Income Growth)

Five-year net income growth must be positive. Northrop's earnings per share reached $29.08 in fiscal year 2025 — up 2.6% year over year and consistent with a multi-year trend of profitable growth. Revenue has grown from approximately $36 billion in 2022 to nearly $42 billion in 2025. The growth rate is modest relative to high-growth technology companies, but defense contractors prioritize predictability and margin discipline over aggressive top-line expansion. Given 2026 guidance for adjusted EPS of $27.40–$27.90 (reflecting accounting adjustments), the long-term earnings trajectory remains intact.

The Bull Case

The B-21 Raider is Northrop's generational platform — and ramp-up is just beginning. The U.S. Air Force has stated a requirement for at least 100 B-21 bombers, with production expected to ramp meaningfully in 2027 and 2028 as the Air Force secured contract acceleration funding. Northrop noted that this B-21 upside is not yet reflected in its 2026 guidance — suggesting significant earnings visibility that isn't priced in. This is not a speculative program; it's the centerpiece of U.S. nuclear deterrence strategy.

The record $95.7 billion backlog provides years of revenue visibility. Northrop ended fiscal year 2025 with its highest-ever backlog, up substantially from prior years. A backlog nearly 2.3x annual revenue means the company has locked-in demand well into the next decade. For investors accustomed to technology businesses where revenue can evaporate overnight, this level of contract certainty is rare.

International defense spending is structurally accelerating. Northrop's international sales surged 32% year over year in Q3 2025, and Defense Systems international revenue was up 55% year over year — driven by NATO member nations increasing defense budgets in response to persistent geopolitical threats. This is not a one-quarter blip; it reflects a multi-year secular shift in global defense spending that Northrop is uniquely positioned to capture.

The GBSD program is a decades-long annuity. Northrop's Ground Based Strategic Deterrent program — the replacement for the Minuteman III ICBM — is one of the largest defense programs in U.S. history. The full-rate production decision brings Northrop into a program that will generate revenue well past 2040. Few companies in any sector can point to a customer contract with that kind of duration.

The stock is up 28% year-to-date in 2026, but analysts still see upside. Despite the strong run, the three most recent analyst price targets from Truist Securities, Morgan Stanley, and Deutsche Bank average approximately $702.67 — suggesting the market may not have fully priced in the B-21 ramp and international growth acceleration.

The Bear Case

Gross margin pressure is structural, not temporary. The government contracting model — especially for classified, sole-source programs — puts a ceiling on margins. Cost-plus contracts compensate Northrop for allowable costs plus a fee, but they limit upside. Fixed-price contracts on development programs (like the early B-21 phases) have historically generated losses industry-wide. As Northrop takes on more fixed-price production work, margin management will be critical.

The B-21 program carries cost and schedule risk. Early production phases of complex weapons systems routinely run over budget. Northrop has absorbed significant cost growth in the B-21's development phase. While the production contract structure is more favorable, large-scale manufacturing of a stealth bomber involves thousands of suppliers and tolerances that are unforgiving. A production setback could pressure near-term earnings.

Free cash flow guidance is under pressure. While FCF was strong in 2025, elevated capital expenditures related to B-21 and GBSD facilities are expected to constrain free cash flow in 2026. The company's cash generation profile will be lumpy as these capital-intensive programs hit their investment peaks before revenue ramps fully.

Political budget risk is real. Defense budgets are subject to Congressional appropriations and continuing resolutions. Any delay in budget approval — through a government shutdown, debt ceiling standoff, or shifting political priorities — can slow contract obligations and payment timing. The proposed executive scrutiny on defense contractor executive compensation and shareholder returns adds another layer of near-term policy uncertainty.

The 2026 EPS guidance implies a year-over-year decline. Northrop's 2026 adjusted EPS guidance of $27.40–$27.90 is lower than the $29.08 reported for fiscal year 2025, reflecting accounting differences and timing of program charges. Investors unfamiliar with defense contractor EPS mechanics may misread this as deterioration. But it does mean near-term earnings growth is not the primary investment thesis — the thesis is long-duration backlog and the B-21/GBSD ramp.

Valuation Overview

Northrop Grumman trades at approximately $727 per share as of mid-March 2026, with a market cap above $107 billion. Key valuation metrics:

• Trailing P/E: ~25x — above its 5-year average of ~19x and 3-year average of ~23x, reflecting the recent strong run
• Earnings Yield: ~3.9% — above the 3.5% Buffettology threshold but at the thin end
• Forward P/E: Implied at ~26x based on 2026 adjusted EPS guidance of $27.40–$27.90
• 2026 Revenue Guidance: $43.5B–$44.0B, representing approximately 4-5% growth over 2025
• Analyst Consensus Price Target: The broad consensus sits around $572–$675, though the most recent targets from top-tier banks average ~$702
• Dividend: Northrop pays a quarterly dividend, contributing to total return for income-oriented investors

At current prices, NOC trades at a notable premium to its historical P/E averages — though still below the Industrials sector average of ~29.8x. The stock's 28% year-to-date gain in 2026 has compressed the margin of safety that value-oriented investors typically require. The investment case leans heavily on the B-21 production ramp, GBSD execution, and international sales acceleration materializing as expected in 2027 and 2028.

The Buffettology Verdict

Northrop Grumman's 8/9 Buffettology score reflects what the company genuinely is: a high-quality, deeply moated business operating in a framework that structurally limits gross margins. The one failing criterion — the gross margin threshold — is an artifact of defense contracting economics, not a sign of competitive weakness. In fact, Northrop's real moat may be more durable than those of many 9/9 companies: its customers are sovereign governments, its programs are classified, and its contracts span decades.

The core tension for investors today is timing and valuation. The business quality is undeniable. The $95.7 billion backlog, 25% ROE, and $3.3 billion in free cash flow reflect a company executing at a high level. But at 25x trailing earnings — well above historical norms — much of the B-21 and international growth narrative is being reflected in the stock price. The incremental upside depends on whether the B-21 ramp and GBSD ramp arrive on schedule and at expected margins.

For investors who want exposure to a premier defense franchise with decades of locked-in demand, Northrop Grumman is difficult to find fault with on fundamentals. The question isn't whether it's a good business — it is. The question is whether today's price already reflects it.

Check NOC on Buffett Score

For more data-driven stock discovery, download Vetted to find quality companies that meet rigorous fundamental criteria.